Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Pilot Evaluation of Ketamine-Enhanced Psychotherapy in Individuals With Alcohol Use Disorder (AUD) and Co-morbid Major Depressive Disorder (MDD)

NCT07247370 is registered in ClinicalTrials.gov with South West Sydney Local Health District as lead sponsor.

NCT NCT07247370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07247370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Pilot Evaluation of Ketamine-Enhanced Psychotherapy in Individuals With Alcohol Use Disorder (AUD) and Co-morbid Major Depressive Disorder (MDD)
Lead sponsor
South West Sydney Local Health District
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
December 10, 2025
Completion date
December 10, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), comorbidities and coexisting conditions, major depressive disorder (mdd)